VGD-071

N/A

Report date: 2023/03/12 14:23:34
NME

Base Information

Drug NameVGD-071
Drug Alias NameVGD-071
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSortilin inhibitors
TargetsSortilin
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Gothenburg
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Gothenburg
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A